We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are OK with this.     OK  No, I would like to know more...
Background Landing Page FAQ ADCs

Case study - ADC Bioconjugation: development and cGMP manufacturing of a candidate for Phase I clinical trials

ADC Bionconjugation Case Study Cover novasep

Antibody Drug Conjugates (ADCs) are fulfilling their promise as a new therapeutic class for the treatment of cancer.

But ADCs are complex multicomponent molecules presenting unique manufacturing challenges as it requires experience of both biological and small molecule manufacturing, combined with HPAPI handling and cGMP facilities.

As a drug innovator working in the ADC field, do you face challenges to develop and manufacture your ADC drug candidate?

With more than 15 years’ experience, Novasep offers a full and flexible range of CDMO services for ADCs.

Discover how we supported one of our clients with the development and cGMP manufacturing of its ADC for Phase I clinical trials in our latest case study!

 
 
Thank you for your submission ! You can now download your file by clicking on the button below:

Back to resources